Published in AIDS Weekly, February 24th, 1997
The answer, in a nutshell, is that the complex dosages, toxicities, and drug interactions of these treatments make them hard for patients to take and difficult for doctors to prescribe.
But new drugs under development - and new combinations including existing drugs - hold the promise of improved, individualized treatment strategies.
"There is reason for hope amid the hype," said long-time AIDS clinician Ann Collier of the University of Washington, Seattle.
Collier discussed the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.